[1]
J. K. Gałązka, Łukasz Domagalski, P. Homa, and Z. Hoffman, “Psoriasiform lesions as a side effect of SGLT-2 therapy”, Qual Sport, vol. 9, no. 1, pp. 35–39, Jan. 2023.